DK0894141T3 - Hybridproteiner, som danner heterodimere - Google Patents
Hybridproteiner, som danner heterodimereInfo
- Publication number
- DK0894141T3 DK0894141T3 DK97906604T DK97906604T DK0894141T3 DK 0894141 T3 DK0894141 T3 DK 0894141T3 DK 97906604 T DK97906604 T DK 97906604T DK 97906604 T DK97906604 T DK 97906604T DK 0894141 T3 DK0894141 T3 DK 0894141T3
- Authority
- DK
- Denmark
- Prior art keywords
- subunit
- coexpressed
- sequence contains
- hybrid proteins
- form heterodimers
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108020004414 DNA Proteins 0.000 abstract 1
- 101001125540 Homo sapiens 26S proteasome regulatory subunit 6A Proteins 0.000 abstract 1
- 101000653510 Homo sapiens TATA box-binding protein-like 2 Proteins 0.000 abstract 1
- 101000891654 Homo sapiens TATA-box-binding protein Proteins 0.000 abstract 1
- 102100026720 Interferon beta Human genes 0.000 abstract 1
- 108090000467 Interferon-beta Proteins 0.000 abstract 1
- 108090001005 Interleukin-6 Proteins 0.000 abstract 1
- 102100030631 TATA box-binding protein-like 2 Human genes 0.000 abstract 1
- 102100040296 TATA-box-binding protein Human genes 0.000 abstract 1
- 101710113649 Thyroid peroxidase Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000000833 heterodimer Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/22—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of other functional groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1193696P | 1996-02-20 | 1996-02-20 | |
| EP97906604A EP0894141B1 (en) | 1996-02-20 | 1997-02-20 | Hybrid proteins which form heterodimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0894141T3 true DK0894141T3 (da) | 2005-08-22 |
Family
ID=21752599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97906604T DK0894141T3 (da) | 1996-02-20 | 1997-02-20 | Hybridproteiner, som danner heterodimere |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US6193972B1 (da) |
| EP (1) | EP0894141B1 (da) |
| JP (2) | JP4140927B2 (da) |
| KR (1) | KR100369985B1 (da) |
| CN (1) | CN1261579C (da) |
| AT (1) | ATE295887T1 (da) |
| AU (1) | AU706504B2 (da) |
| BG (1) | BG64510B1 (da) |
| BR (1) | BR9707589A (da) |
| CA (1) | CA2245877C (da) |
| CZ (1) | CZ291212B6 (da) |
| DE (1) | DE69733309T2 (da) |
| DK (1) | DK0894141T3 (da) |
| EA (1) | EA002474B1 (da) |
| EE (1) | EE04025B1 (da) |
| ES (1) | ES2241040T3 (da) |
| HU (1) | HUP9900619A3 (da) |
| IL (1) | IL125864A (da) |
| NO (1) | NO321777B1 (da) |
| NZ (1) | NZ331539A (da) |
| PL (1) | PL187400B1 (da) |
| PT (1) | PT894141E (da) |
| SK (1) | SK282326B6 (da) |
| UA (1) | UA52646C2 (da) |
| WO (1) | WO1997030161A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9900619A3 (en) * | 1996-02-20 | 2001-11-28 | Applied Research Systems | Hybrid proteins which form heterodimers |
| US6635740B1 (en) * | 1997-03-27 | 2003-10-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Ligand/lytic peptide compositions and methods of use |
| CA2301846A1 (en) | 1997-09-04 | 1999-03-11 | Gryphon Sciences | Modular protein libraries and methods of preparation |
| EA006605B1 (ru) * | 2000-02-22 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ |
| US20030228600A1 (en) * | 2000-07-14 | 2003-12-11 | Eppendorf 5 Prime, Inc. | DNA isolation method and kit |
| IL147414A0 (en) * | 2001-12-31 | 2002-08-14 | Yeda Res & Dev | Ifnar2 mutants, their production and use |
| US20030157091A1 (en) * | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
| DE10247755B4 (de) * | 2002-10-14 | 2006-01-19 | Pfizenmaier, Klaus, Prof. Dr. | Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine |
| BRPI0507174A (pt) * | 2004-01-28 | 2008-04-01 | Syntonix Pharmaceuticals Inc | proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade |
| WO2006067210A1 (en) | 2004-12-23 | 2006-06-29 | Laboratoires Serono S.A. | Bcma polypeptides and uses thereof |
| US7691611B2 (en) | 2005-06-03 | 2010-04-06 | Ares Trading S.A. | Production of recombinant IL-18 binding protein |
| EP2200634B1 (en) * | 2007-09-21 | 2015-02-11 | The Regents of The University of California | Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| CN101960014B (zh) * | 2008-02-01 | 2013-10-16 | 克罗莫塞尔公司 | 细胞系以及制备和使用其的方法 |
| CN102002495B (zh) * | 2009-08-31 | 2012-07-18 | 成都蓉生药业有限责任公司 | 用于表达异二聚体糖蛋白激素的表达框、表达载体及制备方法 |
| CN107840894A (zh) * | 2011-03-25 | 2018-03-27 | 格兰马克药品股份有限公司 | 异二聚体免疫球蛋白 |
| CA2901226C (en) | 2013-02-18 | 2020-11-17 | Vegenics Pty Limited | Vascular endothelial growth factor binding proteins |
| JP7439372B2 (ja) * | 2018-06-21 | 2024-02-28 | シャタック ラボ，インコーポレイテッド | ヘテロ二量体タンパク質及びその使用 |
| KR20220012256A (ko) * | 2019-05-24 | 2022-02-03 | 프로비바 테라퓨틱스 (홍콩) 리미티드 | Il-2 조성물 및 이의 사용 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0325224B1 (en) * | 1988-01-22 | 1996-07-31 | ZymoGenetics, Inc. | Methods of producing secreted receptor analogs |
| US6225449B1 (en) * | 1991-10-04 | 2001-05-01 | Washington University | Hormone analogs with multiple CTP extensions |
| US5705478A (en) * | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| AU5355790A (en) * | 1989-04-19 | 1990-11-16 | Cetus Corporation | Multifunctional m-csf proteins and genes encoding therefor |
| US5650150A (en) * | 1990-11-09 | 1997-07-22 | Gillies; Stephen D. | Recombinant antibody cytokine fusion proteins |
| IL99120A0 (en) * | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| US5932448A (en) * | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
| NZ251820A (en) | 1992-03-30 | 1996-07-26 | Immunex Corp | Fusion proteins with tnf-r (tumour necrosis factor-receptor) peptide linked to another tnf-r or an il-1r (interleukin-1-receptor) peptide |
| US5447851B1 (en) * | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
| IL111125A0 (en) * | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
| HUP9900619A3 (en) * | 1996-02-20 | 2001-11-28 | Applied Research Systems | Hybrid proteins which form heterodimers |
| US6194177B1 (en) * | 1996-02-20 | 2001-02-27 | Applied Research Systems Ars Holding N.V. | DNA encoding a hybrid heterodimeric protein |
-
1997
- 1997-02-20 HU HU9900619A patent/HUP9900619A3/hu unknown
- 1997-02-20 EA EA199800744A patent/EA002474B1/ru not_active IP Right Cessation
- 1997-02-20 IL IL125864A patent/IL125864A/en not_active IP Right Cessation
- 1997-02-20 AU AU21252/97A patent/AU706504B2/en not_active Ceased
- 1997-02-20 WO PCT/US1997/002315 patent/WO1997030161A1/en active IP Right Grant
- 1997-02-20 CN CNB971924112A patent/CN1261579C/zh not_active Expired - Fee Related
- 1997-02-20 SK SK1148-98A patent/SK282326B6/sk unknown
- 1997-02-20 UA UA98094928A patent/UA52646C2/uk unknown
- 1997-02-20 KR KR10-1998-0706215A patent/KR100369985B1/ko not_active IP Right Cessation
- 1997-02-20 CA CA2245877A patent/CA2245877C/en not_active Expired - Fee Related
- 1997-02-20 DE DE69733309T patent/DE69733309T2/de not_active Expired - Lifetime
- 1997-02-20 ES ES97906604T patent/ES2241040T3/es not_active Expired - Lifetime
- 1997-02-20 US US08/804,166 patent/US6193972B1/en not_active Expired - Lifetime
- 1997-02-20 JP JP52949897A patent/JP4140927B2/ja not_active Expired - Fee Related
- 1997-02-20 DK DK97906604T patent/DK0894141T3/da active
- 1997-02-20 PL PL97328454A patent/PL187400B1/pl not_active IP Right Cessation
- 1997-02-20 AT AT97906604T patent/ATE295887T1/de not_active IP Right Cessation
- 1997-02-20 BR BR9707589-2A patent/BR9707589A/pt not_active Application Discontinuation
- 1997-02-20 NZ NZ331539A patent/NZ331539A/xx unknown
- 1997-02-20 EP EP97906604A patent/EP0894141B1/en not_active Expired - Lifetime
- 1997-02-20 EE EE9800256A patent/EE04025B1/xx not_active IP Right Cessation
- 1997-02-20 CZ CZ19982644A patent/CZ291212B6/cs not_active IP Right Cessation
- 1997-02-20 PT PT97906604T patent/PT894141E/pt unknown
-
1998
- 1998-08-19 NO NO19983799A patent/NO321777B1/no unknown
- 1998-08-20 BG BG102705A patent/BG64510B1/bg unknown
-
2001
- 2001-01-09 US US09/756,186 patent/US6663867B2/en not_active Expired - Fee Related
-
2003
- 2003-12-01 US US10/724,226 patent/US7291339B2/en not_active Expired - Fee Related
-
2007
- 2007-07-10 JP JP2007181534A patent/JP2008019258A/ja active Pending
- 2007-09-26 US US11/861,835 patent/US20100075402A1/en not_active Abandoned
- 2007-10-30 US US11/929,292 patent/US20090240039A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0894141T3 (da) | Hybridproteiner, som danner heterodimere | |
| DE69535641D1 (de) | Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen | |
| CY1105763T1 (el) | Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους | |
| ATE393222T1 (de) | Dcr3 polypeptid, ein tnfr homolog | |
| ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
| AR046833A1 (es) | Anticuerpos anti-interleuquina-10 | |
| DE69737415D1 (de) | Gespannte, helixformende peptide und verfahren um sie herzustellen | |
| ATE254138T1 (de) | An den erythropoietin-rezeptor bindende zusammensetzungen und peptide | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| DE3855536D1 (de) | Rezeptoren für wachstumshormone | |
| AR013201A1 (es) | Proteina interleuquina-6 receptor interleuquina-6 quimerica soluble, analogos de la misma, una secuencia de adn, un vector de adn, celulas de mamifero transformadas incapaz de generar un animal, un metodo para producir una proteina quimerica, la utilizacion de dicha proteina para la preparacion de u | |
| WADA et al. | Primary structures of and genes for new ribosomal proteins A and B in Escherichia coli | |
| DK0894130T3 (da) | Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse | |
| BRPI0413426A (pt) | antagonistas de receptor novo | |
| AU580350B2 (en) | Process for synthesising peptides | |
| EA200600376A1 (ru) | Антагонисты nogo-рецептора | |
| EP1557432A3 (en) | Hybrid proteins which form heterodimers | |
| DE69635161D1 (de) | Rekombinante hetero-multimerische proteine von dem alpha-beta c4 bp typ | |
| ATE447008T1 (de) | Rre und cte umfassende gentechnische konstrukte und zusammensetzungen und verwendungen davon | |
| ATE260339T1 (de) | Antikörper gegen menschliches restrictin | |
| Springall | Peptide Chemistry: Chemical Society Symposium | |
| DK1401871T3 (da) | Immunologisk bindingsmolekyle, der hæmmer den syncytiale fusion af trophoblastceller |